AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention September 24, 2017 Biogen Halts Plans to Develop Tysabri for Stroke After Phase IIb Trial Flop February 6, 2018 3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year November 20, 2017
Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention September 24, 2017